Skip to main content

Abstract

Prader-Willi syndrome (PWS) is a genetic condition caused by a partial deletion of the 15th paternal chromosome. Persons with PWS have a broad range of signs and symptoms. The infant has problems feeding associated with hypotonia, but by 2–4 years of age there is the development of lifelong insatiable appetite often leading to morbid obesity if not strictly managed. Significant behavior problems with temper tantrums and stubbornness also begin around 2–4 year of age. Other features include short stature, characteristic facial features, under-developed genitalia, hypotonia, skin picking, difficulty with vomiting, and often mild intellectual disability. The intensity and range of signs and symptoms of PWS requires the help of a large variety of professionals, and is aided by a PWS interdisciplinary team where available. With careful management of weight and behaviors and with considerable effort, persons with PWS can live longer and healthier lives.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 389.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 499.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prader A, Labhart A, Willi A. Ein syndrom von adipositas, kleinwuchs, kryptorchismus und oligophrenie nach myotonieartigem zustand im neugeborenenalter. Schweiz Med Wochen 1956;86:1260. [German].

    Google Scholar 

  2. Alexander R, Hanson J. Overview of Prader-Willi syndrome. In: Greenswag L, Alexander R, editors. Management of Prader-Willi syndrome. New York: Springer; 1988.

    Google Scholar 

  3. Alexander R, Greenswag L. Medical/nursing interventions. In: Greenswag L, Alexander R, editors. Management of Prader-Willi syndrome. 2nd ed. New York: Springer; 1995.

    Google Scholar 

  4. Alexander R, Greenswag L, Nowak A. Rumination and vomiting in Prader-Willi syndrome. Am J Med Genet. 1987;28:889–95.

    Article  CAS  PubMed  Google Scholar 

  5. Driscoll DJ, Waters MF, Williams CA, Zori R, Glenn C, Avidano K, et al. A DNA methylation imprint, determined by the sex of the parent, distinguishes the angelman and Prader-Willi syndromes. Genomics. 1992;13(4):917–24.

    Article  CAS  PubMed  Google Scholar 

  6. McCandless SE, Committee on Genetics. Clinical report—health supervision for children with Prader-Willi syndrome. Pediatrics. 2011;127:195–204.

    Article  PubMed  Google Scholar 

  7. Cassidy SB, Forsythe M, Heeger S, et al. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet. 1997;68:433–40.

    Article  CAS  PubMed  Google Scholar 

  8. Gunay-Aygun M, Schwartz S, Heeger S, O’Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001;108:E92.

    Article  CAS  PubMed  Google Scholar 

  9. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398–402.

    CAS  PubMed  Google Scholar 

  10. Butler MG, Sturich J, Lee J, et al. Growth standards of infants with Prader-Willi syndrome. Pediatrics. 2011;127:687–95.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Carrel A, Lee P, Mogul H. Growth hormone and Prader-Willi syndrome. In: Butler M, Lee P, Whitman B, editors. Management of Prader-Willi syndrome. 3rd ed. New York: Springer; 2006.

    Google Scholar 

  12. Mogul HR, Lee PD, Whitman BY, Zipf W, Frey M, Myers S, et al. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial. J Clin Endocrinol Metab. 2008;93:1238–45.

    Article  CAS  PubMed  Google Scholar 

  13. Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik A, et al. One year of growth hormone treatment in adults with Prader-Willi syndrome improves body composition: results from a randomized, placebo-controlled study. J Clin Endocrinol Metab. 2010;95:4943–50.

    Article  CAS  PubMed  Google Scholar 

  14. Festen DA, de Weerd AW, van den Bossche RA, Joosten K, Hoeve H, Hokken-Koelega AC. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab. 2006;91:4911–5.

    Article  CAS  PubMed  Google Scholar 

  15. Stevenson DA, Heinemann J, Angulo M, Butler M, Loker J, Rupe N, et al. Deaths due to choking in Prader-Willi syndrome. Am J Med Genet A. 2007;143:484–7.

    Article  PubMed Central  Google Scholar 

  16. Stevenson DA, Anaya TM, Clayton-Smith J, Hall B, Van Allen M, Zori R, et al. Unexpected death and critical illness in Prader-Willi syndrome: report of ten individuals. Am J Med Genet A. 2004;124A:158–64.

    Article  PubMed  Google Scholar 

  17. Schrander-Stumpel CT, Curfs LM, Sastrowijoto P, Cassidy SB, Schrander JJ, Fryns JP. Prader-Willi syndrome: causes of death in an international series of 27 cases. Am J Med Genet A. 2004;124A:333–8.

    Article  PubMed  Google Scholar 

  18. Bakker B, Maneatis T, Lippe B. Sudden death in Prader-Willi syndrome: brief review of five additional cases. Concerning the article by U. Eiholzer et al.: Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS (Horm Res 2005;63:33–39). Horm Res. 2007;67:203–4.

    Article  CAS  PubMed  Google Scholar 

  19. Craig ME, Cowell CT, Larsson P, et al. Growth hormone treatment and adverse events in Prader-Willi syndrome: data from KIGS (the Pfizer International Growth Database). Clin Endocrinol (Oxf). 2006;65:178–85.

    Article  CAS  Google Scholar 

  20. Eiholzer U, Nordmann Y, L’Allemand D. Fatal outcome of sleep apnoea in PWS during the initial phase of growth hormone treatment. A case report. Horm Res. 2002;58 suppl 3:24–6.

    CAS  PubMed  Google Scholar 

  21. Eiholzer U. Deaths in children with Prader-Willi syndrome. A contribution to the debate about the safety of growth hormone treatment in children with PWS. Horm Res. 2005;63:33–9.

    Article  CAS  PubMed  Google Scholar 

  22. Nagai T, Obata K, Tonoki H, Temma S, Murakami N, Katada Y, et al. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A. 2005;136:45–8.

    Article  CAS  PubMed  Google Scholar 

  23. Nordmann Y, Eiholzer U, l’Allemand D, Mirjanic S, Markwalder C. Sudden death of an infant with Prader-Willi syndrome–not a unique case? Biol Neonate. 2002;82:139–41.

    Article  PubMed  Google Scholar 

  24. Sacco M, Di Giorgio G. Sudden death in Prader-Willi syndrome during growth hormone therapy. Horm Res. 2005;63:29–32.

    Article  CAS  PubMed  Google Scholar 

  25. Tauber M, Diene G, Molinas C, Hébert M. Review of 64 cases of death in children with Prader-Willi syndrome (PWS). Am J Med Genet A. 2008;146:881–7.

    Article  Google Scholar 

  26. Akefeldt A, Törnhage CJ, Gillberg C. A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Dev Med Child Neurol. 1999;41:789–90.

    Article  CAS  PubMed  Google Scholar 

  27. Goelz T. Motor and developmental interventions. In: Butler M, Lee P, Whitman B, editors. Management of Prader-Willi syndrome. 3rd ed. New York: Springer; 2006.

    Google Scholar 

  28. Clarke DJ, Boer H, Whittington J, Holland A, Butler J, Webb T. Prader-Willi syndrome, compulsive and ritualistic behaviours: the first population-based survey. Br J Psychiatry. 2002;180:358–62.

    Article  CAS  PubMed  Google Scholar 

  29. Butler MG. Hypopigmentation: a common feature of Prader-Labhart-Willi syndrome. Am J Hum Genet. 1989;45:140–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Greenswag L, Alexander R. Early diagnosis in Prader-Willi syndrome: implications for managing weight and behavior. Dysmorphol Clin Genet. 1990;4:8–12.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Randell C. Alexander M.D., Ph.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Alexander, R.C. (2016). Prader-Willi Syndrome. In: Rubin, I.L., Merrick, J., Greydanus, D.E., Patel, D.R. (eds) Health Care for People with Intellectual and Developmental Disabilities across the Lifespan. Springer, Cham. https://doi.org/10.1007/978-3-319-18096-0_66

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-18096-0_66

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-18095-3

  • Online ISBN: 978-3-319-18096-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics